Revised outcome of the Rights Issue Committee held on November 03, 2026

lBLl Indrayani Biotech Inclusive Growth Date: 03.11.2026 BSE Limited Dept. of Corporate Services, Floor 25, P] Towers, Dalal Street, Mumbai-400001. Scrip Code: 526445 Dear Sir/Madam, Subject: Outcome of Rights Issue Committee Meeting under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”) This is in continuation to our earlier intimations regarding the Rights Issue of Rights Equity Shares of face value ¥10/- each of Indrayani Biotech Limited (“Company”). Pursuant to Regulation 30 and other applicable provisions of the SEBI LODR Regulations, we hereby inform you that the Rights Issue Committee of the Company, at its meeting held today, i.e., November 03, 2026, has considered and approved the Basis of Allotment of 83,64,036 Rights Equity Shares Out of Which 75,03,333 shares at Rs. 15 (including premium of Rs.5) has been fully paid and 8,60,703 shares has been party paid at Rs.3.75(including premium of Rs.1.25) on application (“Allotment”) has been received. The Committee considered, reviewed, and took on record the Basis of Allotment was finalized in consultation with the Designated Stock Exchange, BSE Limited, vide their approval email dated 02 November 2026. Accordingly, pursuant to the Allotment, the paid-up equity share capital of the Company has increased from ¥ 45,53,62,560 comprising of 4,55,36,256 fully paid-up equity shares of X 10 each to X 53,25,47,648 comprising of 5,30,39,589 fully paid-up Equity Shares and 8,60,703 partly paid-up (Rs. 2.50 paid-up) Equity Shares. The Meeting Commenced on 4,30 pm and concluded at 5.30 pm. lBLl Indrayani Biotech = Inclusive Growth Kindly take the above information on your record. - Thanking you, Yours Faithfully For and Behalf of Indrayani Biotech Limited Nangavaram Mahadevan Ranganathan DIN: 06377402 Chairman of the Committee lBL‘ Indraya ni Biotech Inclusive Growth Annexure A Details with respect to issuance of securities, as required under Regulation 30 (6) of SEBI Listing Regulations read SEBI Master Circular No. HO/49/14/14(7)2025- CFDPOD2/1/3762/2026SEBI/HO/CFD/PoD2/CIR/P/0155 dated January 30,2026 DETAILS OF ISSUANCE OF SECURITIES S. No. Details of event(s) that need to be provided Information of such event(s) Type of securities proposed to be issued (viz. Partly paid-up equity equity shares, convertibles etc.); shares of the Company Type of issuance (further public offering, rights Rights issue to the eligible issue, depository receipts (ADR/GDR), qualified equity shareholders of the Company as on the record institutions placement, preferential allotment date etc.); Total number of securities proposed to be Allotment of 83,64,036 issued or the total amount for which the Equity Shares of Face Value securities will be issued (approximately); er-the of Rs. 10 each on Right total untfor-which—th Fiti vill-b. Basis to the eligible issued-(approximately); shareholders and/ or renounce(s) in terms of the Letter of Offer at an issue price of Rs. 15/- per Equity Share (including a premium Rs. 5/- per Equity Share). Out of Which 75,03,333 shares at Rs. 15 (including premium of Rs.5) has been fully paid and 8,60,703 shares has been party paid at Rs.3.75(including premium of Rs.1.25) on application (“Allotment”) and the balance amount shall be payable on next call as defined in the Letter of Offer. Any cancellation or termination of proposal for NA issuance of securities including reasons thereof